KWM
LLY icon

Keebeck Wealth Management’s Eli Lilly LLY Stock Holding History

Keebeck Wealth Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4M Buy
8,672
+2,120
+32% +$2.17M 1.02% 18
2026
Q1 		$6.03M Buy
6,552
+249
+4% +$252K 0.68% 35
2025
Q4 		$6.77M Buy
6,303
+174
+3% +$166K 0.78% 30
2025
Q3 		$4.68M Sell
6,129
-227
-4% -$169K 0.55% 53
2025
Q2 		$4.95M Sell
6,356
-1,373
-18% -$1.07M 0.65% 40
2025
Q1 		$6.38M Buy
7,729
+4
+0.1% +$3.33K 0.94% 21
2024
Q4 		$5.96M Sell
7,725
-421
-5% -$349K 0.86% 26
2024
Q3 		$7.22M Buy
8,146
+793
+11% +$713K 1.05% 21
2024
Q2 		$6.66M Sell
7,353
-23
-0.3% -$18.4K 0.98% 23
2024
Q1 		$5.74M Sell
7,376
-101
-1% -$71.9K 0.84% 27
2023
Q4 		$4.36M Buy
7,477
+318
+4% +$186K 0.72% 34
2023
Q3 		$3.85M Sell
7,159
-3,098
-30% -$1.6M 0.67% 41
2023
Q2 		$4.81M Buy
10,257
+1,274
+14% +$534K 0.66% 44
2023
Q1 		$3.08M Buy
8,983
+858
+11% +$289K 0.5% 54
2022
Q4 		$2.97M Buy
8,125
+366
+5% +$130K 0.52% 51
2022
Q3 		$2.51M Buy
7,759
+941
+14% +$298K 0.48% 51
2022
Q2 		$2.21M Buy
6,818
+882
+15% +$265K 0.42% 60
2022
Q1 		$1.7M Buy
5,936
+617
+12% +$159K 0.28% 86
2021
Q4 		$1.47M Buy
5,319
+300
+6% +$76.1K 0.26% 85
2021
Q3 		$1.16M Sell
5,019
-311
-6% -$76.8K 0.23% 93
2021
Q2 		$1.22M Buy
5,330
+542
+11% +$109K 0.18% 103
2021
Q1 		$895K Buy
4,788
+115
+2% +$22.5K 0.14% 118
2020
Q4 		$789K Buy
4,673
+153
+3% +$22.8K 0.14% 118
2020
Q3 		$668K Buy
4,520
+625
+16% +$96.7K 0.14% 112
2020
Q2 		$638K Buy
3,895
+1,718
+79% +$264K 0.2% 94
2020
Q1 		$301K Sell
2,177
-23
-1% -$3.16K 0.13% 121
2019
Q4 		$288K Buy
+2,200
New +$255K 0.09% 120

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Keebeck Wealth Management's LLY Position: Q2 2026 in Review

Keebeck Wealth Management increased its Eli Lilly (LLY) stake by 32% in Q2 2026, buying an estimated $2.17M and bringing the position to 8,672 shares worth $10.4M. The position accounts for 1.02% of the portfolio, ranked #18.

Keebeck Wealth Management first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Keebeck Wealth Management held 8,672 shares of Eli Lilly worth $10.4M as of Q2 2026.
  • Keebeck Wealth Management bought 2,120 Eli Lilly shares in Q2 2026, an estimated $2.17M.
  • Eli Lilly made up 1.02% of Keebeck Wealth Management's portfolio in Q2 2026, its #18 holding.
  • Keebeck Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Keebeck Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.